Rituximab Sc Vs Rituximab Iv for non-Hodgkin’s Lymphomas (Nhls)- an Economic Evaluation for the Greek Healthcare System
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1099
https://www.valueinhealthjournal.com/article/S1098-3015(15)03175-7/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
601
First Page :
A444
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03175-7&doi=10.1016/j.jval.2015.09.1099